NCT04843852View on ClinicalTrials.gov

TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 16, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

April 1, 2027

Conditions
Hepatitis BChronic Hepatitis B
Interventions
DRUG

Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B]

one 0.5ml intramuscular injection on day 0 and week 4.

Trial Locations (1)

21201

RECRUITING

Institute of Human Virology, University of Maryland School of Medicine, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER

NCT04843852 - TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B | Biotech Hunter | Biotech Hunter